Indication

Nonfunctional neuroendocrine tumor of gastrointestinal origin

A nonfunctional neuroendocrine tumor of gastrointestinal origin is an epithelial neoplasm arising from enterochromaffin or other neuroendocrine cells within the digestive tract, most commonly the small intestine, appendix, stomach, or rectum. Read more about Nonfunctional neuroendocrine tumor of gastrointestinal origin

7 drugs 7 manufacturers

Advertisement

Drugs that treat it

Common Nonfunctional neuroendocrine tumor of gastrointestinal origin therapies.

Showing 1–7 of 7 drugs

AFINITOR (everolimus)

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
Novartis Pharmaceuticals

TORPENZ (everolimus)

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
Upsher-Smith Laboratories

EVEROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
NORTHSTAR RX LL

EVEROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
BIOCON PHARMA I

AFINITOR (everolimus)

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
Novartis Pharmaceuticals

EVEROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
NOVUGEN PHARMA

YULITHIRA (everolimus)

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
CIVICASCRIPT, L
Filter & compare in the drug finder →Opens the drug finder with Nonfunctional neuroendocrine tumor of gastrointestinal origin preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Nonfunctional neuroendocrine tumor of gastrointestinal origin.

A nonfunctional neuroendocrine tumor of gastrointestinal origin is an epithelial neoplasm arising from enterochromaffin or other neuroendocrine cells within the digestive tract, most commonly the small intestine, appendix, stomach, or rectum.

Unlike functional neuroendocrine neoplasms, these tumors do not cause clinical hypersecretion syndromes—such as carcinoid syndrome—because they either produce biologically inactive substances or do not release vasoactive peptides and hormones in quantities sufficient to elicit systemic endocrine symptoms.

Patients are predominantly adults, and because hormonal clues are absent, tumors often follow an indolent early course and are discovered incidentally or at an advanced stage.

Clinical manifestations typically stem from local mass effect, mucosal ulceration, or distant metastases, presenting with nonspecific gastrointestinal symptoms such as abdominal pain, bowel obstruction, bleeding, or palpable hepatomegaly.

Personalize your experience

Follow Nonfunctional neuroendocrine tumor of gastrointestinal origin and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it